Literature DB >> 10664417

Avian influenza virus intranasally inoculated infects the central nervous system of mice through the general visceral afferent nerve.

K Shinya1, A Shimada, T Ito, K Otsuki, T Morita, H Tanaka, A Takada, H Kida, T Umemura.   

Abstract

To define the route of influenza virus invasion into the central nervous system (CNS), an avian influenza A (H5N3) virus was inoculated into mice intranasally or intravenously. Only the intranasal infection group mice showed depression and retention of gas in the digestive system. Pathological findings in the animals were bronchointerstitial pneumonia and non-suppurative encephalitis restricted to the brain stem. The nerve nucleus primarily affected was the nucleus of solitary tract. Prior to the development of the CNS lesions, viral antigen was detected in vagal and trigeminal ganglia. These results suggest that the primarily replicated virus in the respiratory mucosa ascended to the CNS via sensory nerve routes, inducing lesions in the brain stem, and then spread trans-synaptically in the CNS.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10664417     DOI: 10.1007/s007050050016

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  22 in total

Review 1.  The relationship between encephalitis lethargica and influenza: a critical analysis.

Authors:  Sherman McCall; Joel A Vilensky; Sid Gilman; Jeffery K Taubenberger
Journal:  J Neurovirol       Date:  2008-05       Impact factor: 2.643

Review 2.  The Olfactory Bulb: An Immunosensory Effector Organ during Neurotropic Viral Infections.

Authors:  Douglas M Durrant; Soumitra Ghosh; Robyn S Klein
Journal:  ACS Chem Neurosci       Date:  2016-04-08       Impact factor: 4.418

Review 3.  Dysfunctional nucleus tractus solitarius: its crucial role in promoting neuropathogenetic cascade of Alzheimer's dementia--a novel hypothesis.

Authors:  Mak Adam Daulatzai
Journal:  Neurochem Res       Date:  2012-01-05       Impact factor: 3.996

4.  Analysis by single-gene reassortment demonstrates that the 1918 influenza virus is functionally compatible with a low-pathogenicity avian influenza virus in mice.

Authors:  Li Qi; A Sally Davis; Brett W Jagger; Louis M Schwartzman; Eleca J Dunham; John C Kash; Jeffery K Taubenberger
Journal:  J Virol       Date:  2012-06-20       Impact factor: 5.103

5.  Neurovirulence in mice of H5N1 influenza virus genotypes isolated from Hong Kong poultry in 2001.

Authors:  Aleksandr S Lipatov; Scott Krauss; Yi Guan; Malik Peiris; Jerold E Rehg; Daniel R Perez; Robert G Webster
Journal:  J Virol       Date:  2003-03       Impact factor: 5.103

Review 6.  Viral parkinsonism.

Authors:  Haeman Jang; David A Boltz; Robert G Webster; Richard Jay Smeyne
Journal:  Biochim Biophys Acta       Date:  2008-08-12

7.  Olfactory bulb and hypothalamic acute-phase responses to influenza virus: effects of immunization.

Authors:  Mark R Zielinski; Gianne Souza; Ping Taishi; Stewart G Bohnet; James M Krueger
Journal:  Neuroimmunomodulation       Date:  2013-08-16       Impact factor: 2.492

Review 8.  Infectious agents and neurodegeneration.

Authors:  Giovanna De Chiara; Maria Elena Marcocci; Rossella Sgarbanti; Livia Civitelli; Cristian Ripoli; Roberto Piacentini; Enrico Garaci; Claudio Grassi; Anna Teresa Palamara
Journal:  Mol Neurobiol       Date:  2012-08-17       Impact factor: 5.590

Review 9.  In Vivo Models to Study the Pathogenesis of Extra-Respiratory Complications of Influenza A Virus Infection.

Authors:  Edwin Veldhuis Kroeze; Lisa Bauer; Valentina Caliendo; Debby van Riel
Journal:  Viruses       Date:  2021-05-06       Impact factor: 5.048

10.  Replication Kinetics, Cell Tropism, and Associated Immune Responses in SARS-CoV-2- and H5N1 Virus-Infected Human Induced Pluripotent Stem Cell-Derived Neural Models.

Authors:  Lisa Bauer; Bas Lendemeijer; Femke M S de Vrij; Debby van Riel; Lonneke Leijten; Carmen W E Embregts; Barry Rockx; Steven A Kushner
Journal:  mSphere       Date:  2021-06-23       Impact factor: 4.389

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.